AI drug discovery

R&D

Patentability and predictability in AI-assisted drug discove...

Artificial intelligence (AI) and machine learning (ML) are ushering in a new era in drug discovery.

Digital

An investor’s perspective on bio and tech

Increasingly, the life sciences world is characterised by the collision of the worlds of technology and biology.

Digital

AI drug discovery: Where we are and where we’re going

The promise of AI in pharma is sprouting up across the business, from marketing to manufacturing to R&D.

R&D

Talking techbio with NVIDIA: Accelerated computing, NLP, and...

As Genentech and NVIDIA enter into a multi-year strategic AI research collaboration to accelerate drug discovery and development, web editor Nicole Raleigh revisits a recent discussion with

News

Genentech, NVIDIA partner on ‘lab-in-a-loop’ AI platform

NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s Genentech subsidiary aimed at accelerating the use of generative artifici

Digital